Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Link Pharma Chem Ltd is a mid-sized chemical manufacturing company founded in 1986, specializing in thionyl chloride and other chemical intermediates for pharmaceutical, agro-industrial, and specialty chemical applications.
The company has a robust capacity for carrying out corrosive chemical reactions, equipped with advanced reactor technologies to meet diverse industry needs.
Notable for expanding thionyl chloride production capacity from 300 TPA to 3300 TPA, indicating significant operational growth and market demand fulfillment.
LPCL has a strategic buy-back arrangement with Gharda Chemicals for over 35% of its thionyl chloride capacity, ensuring steady revenue streams.
The merger with a chlorinated paraffin manufacturing firm has broadened its product range and strengthened its market positioning.
Chemicals & Petrochemicals
Commodity Chemicals
11 Cr
High Risk
138.8
42.5
1.4
0.9
41.90
21.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Link Pharma Chem Ltd (LINKPH) is currently trading at 25.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Link Pharma Chem Ltd is a mid-sized chemical manufacturing company founded in 1986, specializing in thionyl chloride and other chemical intermediates for pharmaceutical, agro-industrial, and specialty chemical applications. The company has a robust capacity for carrying out corrosive chemical reactions, equipped with advanced reactor technologies to meet diverse industry needs. Notable for expanding thionyl chloride production capacity from 300 TPA to 3300 TPA, indicating significant operational growth and market demand fulfillment. LPCL has a strategic buy-back arrangement with Gharda Chemicals for over 35% of its thionyl chloride capacity, ensuring steady revenue streams. The merger with a chlorinated paraffin manufacturing firm has broadened its product range and strengthened its market positioning.
Over the past 52 weeks, Link Pharma Chem Ltd has traded between a low of ₹21.00 and a high of ₹41.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Link Pharma Chem Ltd has a market capitalization of approximately 11.10. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Link Pharma Chem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 138.75 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 11.10 Cr, Link Pharma Chem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Link Pharma Chem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Link Pharma Chem Ltd is 138.75. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
4
Neutral
5
Bullish
5
Bearish
31
Neutral
5
Bullish
10
Bearish
27
Neutral
0
Bullish
5
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
164.30 | 15 Cr | 739.50 | 3.72 | 0.00 | 0.72 | 6.65 | 0.06 | ||
25.34 | 13 Cr | 29.47 | 1.56 | 0.00 | 5.37 | 6.69 | 4.51 | ||
27.10 | 11 Cr | -56.90 | 0.81 | 0.00 | -1.63 | -0.52 | -1.13 | ||
25.00 | 11 Cr | 138.75 | 0.87 | 0.00 | 0.60 | 3.31 | 0.32 | ||
9.99 | 9 Cr | 5.16 | 0.46 | 0.00 | 10.10 | 8.40 | 2.46 | ||
13.45 | 9 Cr | -48.61 | 4.87 | 0.00 | -9.59 | -2.15 | -1.31 | ||
36.00 | 8 Cr | 2.55 | 1.15 | 0.00 | 45.06 | 40.03 | 31.38 | ||
| Median: 7 Co. | — | 25.34 | 11 Cr | 5.16 | 1.15 | 0.00 | 0.72 | 6.65 | 0.32 |
AGM/EGM Notice
Link Pharma Chem Ltd dispatched letters with web-link to the Annual Report 2025-26 pursuant to Reg.36(1)(b); AGM scheduled for 2026-08-20 at 11:30 IST via VC with remote e-voting details and web links provided.
AGM/EGM Notice
Link Pharma Chem Ltd published newspaper advertisements (Business Standard & Loksatta) for the Notice of its 41st AGM to be held on 2026-08-20 at 11:30 IST via Video Conferencing/OVAM, including e‑voting and book closure information.
Board Meeting
Link Pharma Chem Ltd: Board meeting scheduled on 05-08-2026 to consider and approve unaudited financial results for quarter ended 30-06-2026. Trading window closed from 01-07-2026; will reopen 48 hours after results declaration.
AGM/EGM Notice
Link Pharma Chem Ltd: Register of Members and share transfer books closed from 14-20 Aug 2026 for 41st AGM on 20 Aug 2026 at 11:30 AM via VC/OAVM. Cut-off date for remote e-voting: 13 Aug 2026.
AGM/EGM Notice
Link Pharma Chem Ltd announces book closure from 14-08-2026 to 20-08-2026 for record of shareholders for the 41st AGM on 20-08-2026 at 11:30 A.M. via VC/OAVM; cut-off date for remote e-voting is 13-08-2026.
AGM/EGM Notice
Link Pharma Chem Ltd convenes its 41st AGM on 2026-08-20 at 11:30 A.M. (IST) via VC/OAVM; agenda includes adoption of audited FY2025-26 financials, re-appointment of Chairman & MD, and auditor appointments/ratification.
